AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35267911 — intervention group
Group type: COMPARATOR
Intervention: Maintained euhydration (EUH) during walking/running at 55% V.O2max, 40 °C
Number of subjects: 10
Study 35267911 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-restricted (DEH)
Number of subjects: 10
Study 35690783 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 61
Study 34742285 — intervention group
Group type: EXPERIMENTAL
Intervention: Shamba Maisha intervention
Number of subjects: 34
Study 34742285 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 34
Study 35695947 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Comprehensive Behavioral Intervention for Tics (CBIT)
Number of subjects: 55
Study 35695947 — intervention group
Group type: COMPARATOR
Intervention: Group Educational Intervention for Tics (EIT)
Number of subjects: 55
Study 36457090 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg
Number of subjects: 62
Study 36457090 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 33849030 — intervention group
Group type: EXPERIMENTAL
Intervention: Postnatal closure cohort
Number of subjects: 163
Study 33849030 — intervention group
Group type: COMPARATOR
Intervention: Prenatal closure cohort
Number of subjects: 163
Study 616120383 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-VEGF injections
Number of subjects: 40
Study 33269580 — intervention group
Group type: EXPERIMENTAL
Intervention: Vagitories based on tea tree oil
Number of subjects: 210
Study 33269580 — intervention group
Group type: EXPERIMENTAL
Intervention: St. John's wort-based vagitories
Number of subjects: 210
Study 33269580 — intervention group
Group type: EXPERIMENTAL
Intervention: Five herbs-based vagitories
Number of subjects: 210
Study 33269580 — intervention group
Group type: EXPERIMENTAL
Intervention: Vagitories based on St. John's wort
Number of subjects: 210
Study 33269580 — intervention group
Group type: EXPERIMENTAL
Intervention: Vagitories based on extracts of five plants
Number of subjects: 210
Study 33269580 — intervention group
Group type: EXPERIMENTAL
Intervention: All investigated vagitories
Number of subjects: 210
Study 33092618 — intervention group
Group type: EXPERIMENTAL
Intervention: Home non-invasive ventilation (NIV) strategies: 'rescue', 'non-targeted', and 'targeted'
Number of subjects: 0
Study 33092618 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted home NIV with personalized ventilation settings and extensive monitoring
Number of subjects: 0
Study 33092618 — intervention group
Group type: COMPARATOR
Intervention: No-home NIV
Number of subjects: 0
Study 33858718 — intervention group
Group type: EXPERIMENTAL
Intervention: MMRV (two doses)
Number of subjects: 3705
Study 33858718 — intervention group
Group type: EXPERIMENTAL
Intervention: MMR + V (one dose of MMR followed by one dose of V)
Number of subjects: 3705
Study 33858718 — intervention group
Group type: COMPARATOR
Intervention: MMR (control group, two doses)
Number of subjects: 3705
Study 33858718 — intervention group
Group type: EXPERIMENTAL
Intervention: MMRV and MMR + V groups
Number of subjects: 3705
Study 33858718 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 3705
Study 36028843 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief intervention using genetic polymorphism information (genotype testing using saliva, 30-min face-to-face or online intervention)
Number of subjects: 0
Study 36028843 — intervention group
Group type: COMPARATOR
Intervention: Conventional materials provided to the control group
Number of subjects: 0
Study 33803814 — intervention group
Group type: EXPERIMENTAL
Intervention: HAplus gel (Aminogam gel®) applied to gingival tissue post-extraction
Number of subjects: 0
Study 33803814 — intervention group
Group type: EXPERIMENTAL
Intervention: HAplus gel enriched with vitamins C and E (TEST groups)
Number of subjects: 0
Study 33803814 — intervention group
Group type: COMPARATOR
Intervention: HA-Control (HAplus-enriched medium without additional vitamins)
Number of subjects: 0
Study 35388554 — intervention group
Group type: EXPERIMENTAL
Intervention: Participatory ergonomic (PE) intervention
Number of subjects: 263
Study 35388554 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 263
Study 33634332 — intervention group
Group type: EXPERIMENTAL
Intervention: All-inside technique
Number of subjects: 80
Study 33634332 — intervention group
Group type: COMPARATOR
Intervention: Anteromedial portal technique (AMP)
Number of subjects: 80
Study 32144829 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative pelvic floor muscle training (PFMT) daily from inclusion to surgery (n=81)
Number of subjects: 159
Study 32144829 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention; n=78)
Number of subjects: 159
Study 32144829 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall changes in all patients after surgery
Number of subjects: 159
Study 34389577 — intervention group
Group type: EXPERIMENTAL
Intervention: Transitional Pain Service (TPS)
Number of subjects: 176
Study 34389577 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 176
Study 35578230 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual therapy (maximum of 6 sessions within 6 weeks, including spinal manipulation/mobilization, massage, and stretching)
Number of subjects: 409
Study 35578230 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual therapy
Number of subjects: 409
Study 35578230 — intervention group
Group type: COMPARATOR
Intervention: Advice to stay active (information from a physician on coping with pain, at 2 occasions within 3 weeks)
Number of subjects: 409
Study 35578230 — intervention group
Group type: COMPARATOR
Intervention: Advice to stay active
Number of subjects: 409
Study 33422394 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacifier before feeding
Number of subjects: 72
Study 36420808 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Mental Rehearsal (GMR)
Number of subjects: 80
Study 36420808 — intervention group
Group type: COMPARATOR
Intervention: Peer-learning (Control)
Number of subjects: 80
Study 33629490 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemoglobin levels of 70-89 g/l at 6+0 - 13+6 weeks
Number of subjects: 11976
Study 33629490 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemoglobin levels at 26-30 weeks of gestation
Number of subjects: 11976
Study 33629490 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemoglobin levels at 6+0 - 13+6 weeks and at 26-30 weeks of gestation
Number of subjects: 11976
Study 33276610 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal self-referral
Number of subjects: 0
Study 33276610 — intervention group
Group type: COMPARATOR
Intervention: Referral by community agency staff
Number of subjects: 0
Study 33276610 — intervention group
Group type: COMPARATOR
Intervention: Referral by research staff
Number of subjects: 0
Study 36482258 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg NMN
Number of subjects: 80
Study 36482258 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg NMN
Number of subjects: 80
Study 36482258 — intervention group
Group type: EXPERIMENTAL
Intervention: 900 mg NMN
Number of subjects: 80
Study 36482258 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 36482258 — intervention group
Group type: EXPERIMENTAL
Intervention: NMN (all doses)
Number of subjects: 80
Study 36482258 — intervention group
Group type: EXPERIMENTAL
Intervention: HOMA-IR (all NMN doses)
Number of subjects: 80
Study 33902326 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased outdoor time
Number of subjects: 51
Study 33902326 — intervention group
Group type: EXPERIMENTAL
Intervention: Lack of outdoor time, school, and structured activities
Number of subjects: 51
Study 33902326 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased snacking and more meals prepared and consumed at home
Number of subjects: 51
Study 33902326 — intervention group
Group type: EXPERIMENTAL
Intervention: Shift in sleep schedules
Number of subjects: 51
Study 33902326 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in leisure-based screen time
Number of subjects: 51
Study 33902326 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental involvement in promoting activity and managing screen time
Number of subjects: 51
Study 35679184 — intervention group
Group type: EXPERIMENTAL
Intervention: ENB‐EBUS‐GS group
Number of subjects: 385
Study 35679184 — intervention group
Group type: COMPARATOR
Intervention: EBUS‐GS group
Number of subjects: 385
Study 33772133 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP + CaCl2 solution
Number of subjects: 16
Study 33772133 — intervention group
Group type: COMPARATOR
Intervention: CaCl2 only
Number of subjects: 16
Study 33772133 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 16
Study 32891336 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional jejunal interposition
Number of subjects: 113
Study 32891336 — intervention group
Group type: COMPARATOR
Intervention: Roux-en-Y anastomosis
Number of subjects: 113
Study 35711607 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular plaster therapy (APT)
Number of subjects: 80
Study 35711607 — intervention group
Group type: COMPARATOR
Intervention: Placebo/control APT
Number of subjects: 80
Study 34222540 — intervention group
Group type: EXPERIMENTAL
Intervention: Benson's relaxation technique (listened to a voice containing relaxation technique twice a day for eight weeks)
Number of subjects: 80
Study 34222540 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 80
Study 32395833 — intervention group
Group type: EXPERIMENTAL
Intervention: CT radiomics model based on a multicentric heterogeneous dataset with robust feature pre-selection (MCR)
Number of subjects: 124
Study 32395833 — intervention group
Group type: COMPARATOR
Intervention: CT radiomics model based on a smaller standardized dataset without pre-selection (STD)
Number of subjects: 124
Study 33515539 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceritinib + AKT inhibitors (Capivasertib and Afuresertib)
Number of subjects: 0
Study 33515539 — intervention group
Group type: COMPARATOR
Intervention: AKT inhibitors (Capivasertib and Afuresertib) alone
Number of subjects: 0
Study 33121605 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis (AP) prescribing for invasive dental procedures in high-risk patients
Number of subjects: 160
Study 33121605 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis (AP) prescribing for invasive dental procedures in moderate-risk patients
Number of subjects: 160
Study 33121605 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis (AP) prescribing for invasive dental procedures in low or unknown risk patients
Number of subjects: 160
Study 36087590 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg orally every 12 h for 7 days followed by 4 mg orally every 12 h for 7 days
Number of subjects: 149
Study 36087590 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules for 14 days
Number of subjects: 149
Study 36087590 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 149
Study 36087590 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study 32479903 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial photodynamic therapy (aPDT) with chloro-aluminum phthalocyanine (AlClPc) and scaling and root planning (SRP)
Number of subjects: 63
Study 32479903 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planning (SRP) only
Number of subjects: 63
Study 35780318 — intervention group
Group type: EXPERIMENTAL
Intervention: PTW Advanced Markus chamber
Number of subjects: 0
Study 35780318 — intervention group
Group type: EXPERIMENTAL
Intervention: IBA PPC05 chamber
Number of subjects: 0
Study 35780318 — intervention group
Group type: COMPARATOR
Intervention: Proton graphite calorimeter
Number of subjects: 0
Study 32792317 — intervention group
Group type: COMPARATOR
Intervention: LDPRO
Number of subjects: 3
Study 32792317 — intervention group
Group type: COMPARATOR
Intervention: HLPRO
Number of subjects: 3
Study 34085999 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow training group (SLDS e in 6 seconds)
Number of subjects: 36
Study 34085999 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast training group (SLDS e in 3 seconds)
Number of subjects: 36
Study 34085999 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 36
Study 34085999 — intervention group
Group type: EXPERIMENTAL
Intervention: Both experimental groups (slow and fast training)
Number of subjects: 36
Study 32473674 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab
Number of subjects: 0
Study 32473674 — intervention group
Group type: COMPARATOR
Intervention: Adalimumab
Number of subjects: 0
Study 35611518 — intervention group
Group type: EXPERIMENTAL
Intervention: Three times weekly heparin flushing
Number of subjects: 20
Study 35611518 — intervention group
Group type: COMPARATOR
Intervention: Daily heparin flushing (standard of care)
Number of subjects: 20
Study 34459774 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical ventilation and oxygen >30%
Number of subjects: 122
Study 34459774 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIV PC)
Number of subjects: 122
Study 34459774 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine administration
Number of subjects: 122
Study 34459774 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily infusion volume
Number of subjects: 122
Study 34459774 — intervention group
Group type: EXPERIMENTAL
Intervention: Onset of enteral nutrition
Number of subjects: 122
Study 34459774 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemoglobin levels on days 1, 3, and 7
Number of subjects: 122
Study 34459774 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocyte levels during the first 7 days of life
Number of subjects: 122
Study 34459774 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet count during the first 7 days of life
Number of subjects: 122
Study 35764836 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadratus lumborum block (QLB)
Number of subjects: 180
Study 35764836 — intervention group
Group type: COMPARATOR
Intervention: Caudal block
Number of subjects: 180
Study 35764836 — intervention group
Group type: COMPARATOR
Intervention: TAP block
Number of subjects: 180
Study 34559129 — intervention group
Group type: EXPERIMENTAL
Intervention: Zhen Wu Decoction (ZWD) with guideline directed medical therapies
Number of subjects: 0
Study 34559129 — intervention group
Group type: COMPARATOR
Intervention: ZWD-granules simulations with guideline directed medical therapies
Number of subjects: 0
Study 35413644 — intervention group
Group type: COMPARATOR
Intervention: Huangkui capsule (HKC) 2.5 g, TID
Number of subjects: 88
Study 35413644 — intervention group
Group type: EXPERIMENTAL
Intervention: Zicuiyin decoction (ZCY) crude drug amount 75 g, 150 ml, BID
Number of subjects: 88
Study 35413644 — intervention group
Group type: COMPARATOR
Intervention: Control group (HKC)
Number of subjects: 88
Study 32964166 — intervention group
Group type: EXPERIMENTAL
Intervention: ICollab intervention for 6 months post-discharge
Number of subjects: 110
Study 32964166 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 110
Study 33155868 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/Valsartan
Number of subjects: 0
Study 32709230 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time monitoring and just-in-time SMS medication reminders
Number of subjects: 1000
Study 32709230 — intervention group
Group type: COMPARATOR
Intervention: Generic weekly SMS reminders
Number of subjects: 1000
Study 35657298 — intervention group
Group type: EXPERIMENTAL
Intervention: m-health intervention integrating Theory of Planned Behavior (TPB) with tailored SMS and web-based knowledge, 8 weeks duration
Number of subjects: 194
Study 35657298 — intervention group
Group type: COMPARATOR
Intervention: Web-based messages alone (control group)
Number of subjects: 194
Study 33880645 — intervention group
Group type: EXPERIMENTAL
Intervention: Management of SAM by lady health workers (LHWs) at community level
Number of subjects: 829
Study 33880645 — intervention group
Group type: COMPARATOR
Intervention: Standard CMAM program at health facility
Number of subjects: 829
Study 32467417 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK2862277 (26 mg nebulised dose)
Number of subjects: 33
Study 32467417 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 32467417 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK2862277
Number of subjects: 33
Study 32467417 — intervention group
Group type: COMPARATOR
Intervention: GSK2862277 and Placebo
Number of subjects: 33
Study 34387353 — intervention group
Group type: COMPARATOR
Intervention: Low medical evidence
Number of subjects: 337
Study 34387353 — intervention group
Group type: COMPARATOR
Intervention: Higher levels of reported pain severity
Number of subjects: 337
Study 35735327 — intervention group
Group type: EXPERIMENTAL
Intervention: Theoretical guide
Number of subjects: 0
Study 35735327 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiovisual guide
Number of subjects: 0
Study 35735327 — intervention group
Group type: COMPARATOR
Intervention: Control group without study
Number of subjects: 0
Study 32740347 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blocker (BB)
Number of subjects: 114
Study 32740347 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitor (ACEi) and/or angiotensin II receptor blocker (ARB)
Number of subjects: 114
Study 36442902 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based multidisciplinary interventions (intensive stage for 6 weeks and maintenance stage for 6 weeks) including health education, follow-up, behaviour guide, social support, skill training, coping with adverse drug reactions, and problem-solving.
Number of subjects: 0
Study 36442902 — intervention group
Group type: COMPARATOR
Intervention: Ordinary care (control group)
Number of subjects: 0
Study 34298035 — intervention group
Group type: EXPERIMENTAL
Intervention: IM trivalent inactivated influenza vaccine
Number of subjects: 70
Study 34298035 — intervention group
Group type: EXPERIMENTAL
Intervention: imi+IM (IM vaccine after topical imiquimod)
Number of subjects: 70
Study 34298035 — intervention group
Group type: EXPERIMENTAL
Intervention: imi+ID (ID vaccine after topical imiquimod)
Number of subjects: 70
Study 35845031 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive lactated Ringer's (LR) infusion
Number of subjects: 136
Study 35845031 — intervention group
Group type: COMPARATOR
Intervention: Aggressive normal saline (NS) infusion
Number of subjects: 136
Study 33620419 — intervention group
Group type: EXPERIMENTAL
Intervention: GDC‐0334 (TRPA1 antagonist)
Number of subjects: 0
Study 33620419 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo or no treatment not specified)
Number of subjects: 0
Study 32072735 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg/day plus saxagliptin 5 mg/day plus metformin
Number of subjects: 82
Study 32072735 — intervention group
Group type: COMPARATOR
Intervention: Glimepiride plus metformin
Number of subjects: 82
Study 34515118 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized exercise programs delivered via smartphone (5 times/week for 6 weeks) including graded exercises for upper/lower body, flexibility, strength, and balance.
Number of subjects: 52
Study 34515118 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized exercise programs delivered via smartphone (5 times/week for 6 weeks).
Number of subjects: 52
Study 32985249 — intervention group
Group type: EXPERIMENTAL
Intervention: Early coronary angiography
Number of subjects: 99
Study 32493523 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard evening meal (ST)
Number of subjects: 96
Study 32493523 — intervention group
Group type: EXPERIMENTAL
Intervention: High-carbohydrate evening meal (HC)
Number of subjects: 96
Study 32493523 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein evening meal (HP)
Number of subjects: 96
Study 33865474 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 35742280 — intervention group
Group type: EXPERIMENTAL
Intervention: Square-stepping exercise (SSE) program, performed for 70 min per session, twice a week, for 12 weeks
Number of subjects: 20
Study 35742280 — intervention group
Group type: EXPERIMENTAL
Intervention: Square-stepping exercise (SSE) program
Number of subjects: 20
Study 35742280 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study 32869937 — intervention group
Group type: EXPERIMENTAL
Intervention: Same side conditioning contraction
Number of subjects: 107
Study 32869937 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossover conditioning contraction
Number of subjects: 107
Study 32869937 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no conditioning contraction)
Number of subjects: 107
Study 36088952 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral amoxicillin–clavulanic acid (75 mg/kg amoxicillin plus 18.75 mg/kg clavulanic acid, given daily in three doses for 7 days)
Number of subjects: 510
Study 36088952 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral amoxicillin–clavulanic acid
Number of subjects: 510
Study 34873188 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost compensation (CC)
Number of subjects: 962
Study 34873188 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision aid (DA)
Number of subjects: 962
Study 34873188 — intervention group
Group type: COMPARATOR
Intervention: Counselling as usual (Control)
Number of subjects: 962
Study 34873188 — intervention group
Group type: COMPARATOR
Intervention: No cost compensation (Control)
Number of subjects: 962
Study 33248603 — intervention group
Group type: COMPARATOR
Intervention: 0 mg/kg natural ASTA
Number of subjects: 450
Study 33248603 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/kg natural ASTA
Number of subjects: 450
Study 33248603 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg/kg natural ASTA
Number of subjects: 450
Study 33248603 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg/kg natural ASTA
Number of subjects: 450
Study 33248603 — intervention group
Group type: EXPERIMENTAL
Intervention: 160 mg/kg natural ASTA
Number of subjects: 450
Study 33248603 — intervention group
Group type: EXPERIMENTAL
Intervention: Storage at 4°C and 25°C
Number of subjects: 450
Study 33248603 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary ASTA level and storage time interaction
Number of subjects: 450
Study 36418274 — intervention group
Group type: EXPERIMENTAL
Intervention: HPSD plus RA
Number of subjects: 60